ArticleInternational journal of cancer2022

Survival, cost and added therapeutic benefit of drugs granted early access through the French temporary authorization for use program in solid tumors from 2009 to 2019.

Fiona Y-V Pham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.